Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Hypertension Congress 2020

About us

Conference series LLC Ltd and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. 

Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", Conferenceseries LLC Ltd publishes scholarly journals in all aspects of Science, Engineering, Management and Technology journals. Conferenceseries LLC Ltd has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. Conferenceseries LLC Ltd also organizes 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

About Conference


Conference series llc LTD is gratified to organize continuing medical education (CME) accredited event 4thInternational Conference on Hypertension & Healthcare” scheduled on March 25-26, 2020 at Tokyo, Japan the place which has the great influx of tourists. The conference mainly runs on the theme “Exploring the new horizons to cure Hypertension & Cardiac diseases “we bring together the brightest and most prolific minds to discuss the interesting concepts of Hypertension and Healthcare diagnosis and management using the modern techniques at Hypertension Congress 2020

  Hypertension congress 2020  mainly  aims to provide an prospect to share the knowledge regarding the Hypertension conference among the large number of medical professionals like , Scientists, Professors , Cardiologists, Researchers, Deans Heads, Directors, and Founders or Writers  and Employees of the related companies of the Hypertension and Healthcare, Cardiology and related departments, Organizations, Associations, Laboratory members and Young researchers working in the field of hypertension treatment and Healthcare management. This conference mainly focuses on spreading awareness about the challenges in the field of hypertension and Healthcare.  This Hypertension Congress or rather all Hypertension related gatheringscardiology events, and Hypertension Conference will help in frameworks organization, B2B uniting amidst specialists, researchers, and academicians. 

Target Audience:

  • Directors of Hypertension or related Programs or Associations
  • Heads, Deans and Professors of Hypertension or Cardiology departments
  • Scientists and Researchers organizers
  • Doctors
  • Medical Colleges
  • Writers
  • Healthcare professionals
  • Founders and Employees of the related companies
  • Clinical investigators
  • Hospitals and Health Services
  • Pharmaceutical companies
  • Laboratory members
  • Training institutions

 

Session/Tracks

 

Track 1: Hypertension

 The disorder   where the   blood pressure  in the   arteries is persistently raised at a constant rate. This is also called as high blood pressure or high vital sign or blood vessel cardiovascular disease. This session categories of cardiovascular disease. The primary disease and secondary disease. Almost 90-95 % of cases are primary and the main cause behind it is the unhealthy lifestyle followed by excessive consumption of alcohol, salt, body weight etc. Remaining 5-10% of individuals suffer this due to thinning of kidney arteries, chronic kidney diseases, and endocrine disorder.  Assessment of cardiovascular disease primarily includes Confirmation of hypertension, Risk factors, Fundamental causes, organ injury & Indications and contraindications of medication. Hypertension could be a major threat issue for cardiopathy and stroke

Track 2:  Pulmonary Hypertension

Pulmonary Hypertension or PH is high blood pressure that affects the arteries in the lungs and the right side of the heart. In one form of pulmonary hypertension, tiny arteries in the lungs and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through the lungs and thus raises the pressure within lung walls. As the pressure builds, the heart's lower right chamber works harder to pump blood through the lungs, eventually causing the heart muscle   fail. Some forms of pulmonary hypertension are serious conditions that become progressively worse and are sometimes fatal. This session mainly talks about the classification, signs, symptoms, and treatments of Pulmonary Hypertension.

Track 3: Pediatric hypertension

     Pediatric   hypertension inclines to hypertension and cardiovascular malady in grown-up life. Despite clear rules, there remains an absence of screening. Determination stays testing given the high rate of false-positive hypertension (BP) readings at a solitary visit; along these lines, different visits are required to affirm the analysis. 

Track 4:   Gestational hypertension

  Hypertension is that the development of recent cardiovascular disease in a very pregnant lady when twenty weeks gestation while not the presence of supermolecule within the excretory product or different signs of  Pre-eclampsia. It's a brief identification for hypertensive pregnant ladies who don't meet criteria for pre-eclampsia or chronic cardiovascular disease. The identification is modified to, pre-eclampsia if a symptom or new signs of end-organ pathology develop and chronic cardiovascular disease if blood pressure elevation persists ≥weeks postnatally.

Track 5Hypertension and Cardiac Arrest

 Cardiac arrest   can be defined as a sudden stop in effective blood flow due to the failure of the heart. It is caused when the heart's electrical system malfunctions. The individual section in the session talks about all the related heart diseases. In cardiac arrest death results when the heart suddenly stops working properly. This may be caused by abnormal, or irregular, heart rhythms, cardiomyopathy (A thickened heart muscle), Heart medications, Electrical abnormalities, Recreational drug uses. Some symptoms of the arrest could be a sudden loss of responsiveness, abnormal breathing, fainting, fatigue, blackouts, dizziness, chest   pain, shortness of breath, weakness, and vomiting. The most common cause for Cardiac arrest is the coronary heart disease. Coronary artery disease often results in coronary ischemia and ventricular fibrillation

Track 6: Hypertension and Obesity

  Hypertension   refers to the pressure that blood applies to the inner walls of the arteries. Obesity increases the chances of cardiovascular disease. The individual session in this focuses on obesity-related cardiovascular disease, its interaction with the outcomes of hypertension, risk factors, treatment and management of cardiovascular disease. Obesity-associated arterial hypertension is characterized by activation of the sympathetic system, activation of the renin-angiotensin system, and sodium retention, among different abnormalities  Anti-hypertension medications ought to be started if hypertension is diagnosed. But, with weight-loss, a major fall in force per unit area could allow a decrease within the range of medicines taken or decrease the quantity of medication taken. Prevention would be better than any drug    . 

Track 7: Hypertension – Stress and Stroke

      Stressful situations can lead the blood to spike up temporarily but sometimes it may cause high blood pressure too. Research is still in progress to find out about it. According to some reports, the change in the blood pressure behavior can be due to various habits like overeating, drinking or poor sleeping. It’s possible that health conditions related to stress like anxiety, depression, and isolation from friends and family may lead to heart disease but not to a high blood pressure condition. Some hormonal changes may damage your arteries leading towards heart disease. According to the National Health Interview Survey, almost 75% of the general population experiences some stress every week.  A stroke occurs when a blood vessel to the brain is either blocked by a clot or bursts, a part of the brain stops to get the required amount of blood and oxygen and hence it starts to die. Since the brain controls the entire body so it can threaten one’s ability to think, move and function. Hence Hypertension is the most prevalent and powerful modifiable risk factor for stroke    .      

    Track 8: Hypertension and Diabetes    

Hypertension can lead to many complications of diabetes. Most people affected with Diabetes are more prone to suffer Hypertension. Diabetes damages the arteries and makes them targets for hardening   and if it is not treated then it may also cause blood vessel damage, heart attack, and kidney failure too. In this section of the main, we discuss various types of Diabetes, risk factors that are involved in it, controlling hypertension in patients with Diabetes and Treatment. 

Track 9: Diet and Exercise for Hypertension

High blood pressure, which is also called hypertension increase the risk of developing many serious health problem   including heart disease, stroke, and kidney disease. Evaluation and Treatment of High Blood Pressure recommendations have defined   hypertension” as a BP of ≥140/90 mm Hg. The risk of cardiovascular disease n the patient with hypertension can be greatly reduced with effective antihypertensive therapy. Maintaining   normal body weight, following a proper diet plan, exercising regularly, avoiding high-sodium content foods, limited alcohol consumption and pressure account.

Track 10:  Hypertension Treatments

 High blood pressure can be cured. The disease can be controlled by following a proper and healthy lifestyle. As per recommended by various doctors by having a healthy lifestyle, eating less salt in your regular diet, quitting smoking, consuming the limited amount of alcohol can help in curing the disease. In addition to this regular exercise will also help in controlling the disease. Drug treatments are available too for Hypertension. Various drugs are available in the market that allows the individual person to do that in which few are-Thiazide diuretics, Beta blockers, Angiotensin II receptor blockers (ARBs), Calcium channel blockers, Central-acting agents, Alpha blockers, Aldosterone antagonists.

Track 11: Advanced Treatments Approaches

Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension, or high blood pressure, is dangerous because it can lead to strokes, heart attacks, heart failure, or kidney disease. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. Treatment for hypertension has been associated with reductions in   stroke ,   heart, and heart failure according to research. Because   hypertension rarely causes specific symptoms, it is not identified until an individual’s blood pressure is measured by a physician or it causes a catastrophic complication such as stroke or heart attack. Accurate diagnosis by blood pressure measurement is essential.

Track 12 Clinical case report

High blood pressure, also known as hypertension, affects millions, even children and teens. It is a common condition that catches up with most people who live into older age. The exact cause of hypertension is unknown, but there are several factors and conditions that may contribute to its occurrence. In the USA about 82% of the total population is suffering from Hypertension.

        Description: https://d2cax41o7ahm5l.cloudfront.net/cs/upload-images/hypertensioncongress-2019-98147.jpg

 

Track 13Causative Factors and Risk Assessment

 High blood pressure has several causative factors like age, race, case history and obesity, not being physically active, overwhelming tobacco, an excessive amount of salt (sodium) in diet, deficient Vitamin D in the diet, drinking an excessive amount of alcohol, stress and bound chronic conditions. Though high pressure is commonest in adults, youngsters are also in danger, too. For a few youngsters, high pressure is caused by issues with the kidneys or heart except for a growing variety of youngsters, poor fashion habits, like an unhealthy diet, fleshiness, physiological condition and lack of exercise contributes to high pressure

 


Market Analysis

According to Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Factors such as technological advancement, a growing aging population, and people suffering from diabetes, Hypertension are favoring the market. On the other hand, increasing health expenditure, hypertension and increasing tobacco users are also fueling the market.

Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive drugs is sustainable and will increase with an increase in the number of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the global sales value of more than USD 40 billion, according to the World Preview 2018 report by Evaluate Pharma.

Some of the key players contributing to the global anti-hypertensive drugs market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd, Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc,  and Takeda Pharmaceutical Company Limited.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

• North America

• Asia Pacific 

• Europe

• Rest of the World

America 

 

 

 

Past Conference Report

Hypertension Congress 2018

We would like to thank all our delightful speakers, students, associations and guests for making Hypertension congress 2018 a wonderful event!

Thank you for being a part in the 3rd    Conference   on   Hypertension & Healthcare (Hypertension Congress 2018).

It was a immense pleasure seeing many well-known faces, and many others who have just joined the Hypertension Congress 2018 at the Radisson   Narita, Tokyo, Japan

Thank you to all the Honorable Guests, Keynote Speakers, Moderator, Chairs, Co-Chairs, Speakers, Students and Delegates, the Organizing Committee and Editorial Board members for their support. The conference would not have been the same without each one of you. We enjoyed hosting the event and hope you walked away with new ideas, inspiration and ambition to promote work in all possible ways.

Conference series   llc   LTD played host to a diverse panel of key members of the Hypertension community from research lab, industry, academia and financial investment practices, discussing the future of Hypertension specialties. This event was really aimed for examining where the real Hypertension specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Hypertension.

Focusing on Hypertension & Obesity, Hypertension Risk factors, Hypertension Diagnosis, Gestational Hypertension, Hypertension Management, Case   Reports & Hypertension Epidemiology as well, the two days of discussions enabled professionals to gain a perception into the current advances and opened networking opportunities.

The highlights of the meeting were the eponymous lectures, delivered by Nditsheni   Ramakuela from University of Venda, South Africa, Christopher Elliott Leman Micro Devices SA, Switzerland, Muhammad  , Nanjing Medical University, China , These talks were of great interest to the general cardiologists and were enormously informative.

Conference series llc LTD 3rd International Conference on Hypertension & Healthcare was a great success with the support of international, multi professional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Hypertension: Open Access, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access.

 

 

   

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 25-26, 2020

For Sponsors & Exhibitors

sponsorship@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Experimental Cardiology Journal of Hypertension Journal of Cardiovascular Diseases & Diagnosis Journal of Clinical & Experimental Cardiology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by